COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses-Reference-Cited by-同舟云学术

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Published:2020-09-30 Issue:7830 Volume:586 Page:594-599
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Sahin Ugur^ORCID,Muik Alexander^ORCID,Derhovanessian Evelyna,Vogler Isabel^ORCID,Kranz Lena M.,Vormehr Mathias^ORCID,Baum Alina,Pascal Kristen^ORCID,Quandt Jasmin^ORCID,Maurus Daniel,Brachtendorf Sebastian,Lörks Verena,Sikorski Julian,Hilker Rolf^ORCID,Becker Dirk,Eller Ann-Kathrin,Grützner Jan,Boesler Carsten,Rosenbaum Corinna,Kühnle Marie-Cristine,Luxemburger Ulrich,Kemmer-Brück Alexandra,Langer David,Bexon Martin^ORCID,Bolte Stefanie,Karikó Katalin^ORCID,Palanche Tania,Fischer Boris,Schultz Armin,Shi Pei-Yong^ORCID,Fontes-Garfias Camila,Perez John L.,Swanson Kena A.^ORCID,Loschko Jakob,Scully Ingrid L.,Cutler Mark,Kalina Warren,Kyratsous Christos A.,Cooper David,Dormitzer Philip R.,Jansen Kathrin U.,Türeci Özlem

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41586-020-2814-7.pdf

Reference37 articles.

1. Mulligan, M. J. et al. Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults. Nature https://doi.org/10.1038/s41586-020-2639-4 (2020).

2. WHO. Coronavirus Disease (COVID-19) Dashboard (accessed 17 September 2020); https://covid19.who.int/

3. Habibzadeh, P. & Stoneman, E. K. The novel coronavirus: a bird’s eye view. Int. J. Occup. Environ. Med. 11, 65–71 (2020).

4. Pardi, N. et al. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. J. Exp. Med. 215, 1571–1588 (2018).

5. Sahin, U., Karikó, K. & Türeci, Ö. mRNA-based therapeutics—developing a new class of drugs. Nat. Rev. Drug Discov. 13, 759–780 (2014).

Cited by 1600 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Mammalian Nudix Enzymes to Capped RNA Analysis;Pharmaceuticals;2024-09-11

2. Management of infections for patient treated with ibrutinib in clinical practice;Frontiers in Oncology;2024-09-10

3. Current landscape of mRNA technologies and delivery systems for new modality therapeutics;Journal of Biomedical Science;2024-09-10

4. Exploratory study of antibody titers against SARS-CoV-2 using an indirect immunoperoxidase assay in COVID-19 patients and vaccinated volunteers;2024-09-09

5. Deciphering the HLA-E immunopeptidome with mass spectrometry: an opportunity for universal mRNA vaccines and T-cell-directed immunotherapies;Frontiers in Immunology;2024-09-05